Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2024.09.023 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von F Mesonero und 50 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Ramón y Cajal (Madrid), Spain; Universidad Alcalá de Henares (Madrid), Spain. Electronic address: pacomeso@hotmail.com. Hauptthemen laut MEDLINE: Pouchitis, Crohn Disease, Colitis, Ulcerative, Proctocolectomy, Restorative. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa.
Abstract (Originalsprache)
BACKGROUND AND AIMS: Inflammatory pouch disorders exhibit a heterogeneous clinical spectrum and therapeutic requirements have not been properly studied. METHODS: This retrospective, multicentre study included ulcerative colitis patients with ileal pouch construction and were later diagnosed with an inflammatory pouch disorder between 1995 and 2020. Classifications, behaviour and therapies applied were recorded and compared in the long-term. RESULTS: Overall, 338 patients were recruited. The most common disorders were pouchitis (n = 258, 76%), Crohn's disease of the pouch (n = 55, 16%) and cuffitis (n = 25, 7%). Pouchitis presented mainly as chronic (65.2%) and recurrent (87%) forms. Crohn's disease manifested as stricturing/penetrating in 53% of cases and perianal disease in 42%. Patients received multiple therapies: 86% antibiotics, 42% steroids, 27% immunosuppressants, 43% biologics and 27% surgery. Compared with pouchitis, Crohn's disease of the pouch was characterised by a later diagnosis (99 vs. 55 months, p < 0.001) and greater needs for immunosuppressants (OR 3.53, 1.79-6.94, p < 0.0001), biologics (OR 5.45, 2.78-10.6, p < 0.0001) and surgeries (OR 2.65, 1.43-4.89, p < 0.001). CONCLUSIONS: Chronic pouchitis is the most common pouch disorder presentation. These entities have diverse therapeutics requirements, particularly for Crohn's disease of the pouch.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Universitario Ramón y Cajal (Madrid), Spain; Universidad Alcalá de Henares (Madrid), Spain. Electronic address: pacomeso@hotmail.com.
- Hospital Universitario Mútua Terrassa (Terrassa), Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
- Hospital Clínic Barcelona (Barcelona), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
- Hospital Universitario Virgen del Rocío (Sevilla), Spain.
- Hospital Universitario Marqués de Valdecilla, Grupo de Investigación Clínica y Traslacional en Enfermedades Digestivas, Instituto de Investigación Sanitaria Valdecilla (IDIVAL) (Santander), Spain.
- Hospital de la Santa Creu i Sant Pau (Barcelona), Spain.
Förderung
- Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Zitieren
APA
Mesonero, F., Zabana, Y., Fernández-Clotet, A., Solá, A., Caballol, B., Leo-Carnerero, E., García, M. J., Bertoletti, F., Bastida, G., Suris, G., Casis, B., Ferreiro-Iglesias, R., Calafat, M., Jiménez, I., Miranda-Bautista, J., Lamuela, L. J., Fajardo, I., Torrealba, L., Nájera, R., …, & GETECCU Young Members Group (2025). Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.09.023
Vancouver
Mesonero F, Zabana Y, Fernández-Clotet A, Solá A, Caballol B, Leo-Carnerero E, et al. Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2024.09.023
BibTeX
@article{Mesonero2025,
author = {Mesonero, F and Zabana, Y and Fernández-Clotet, A and Solá, A and Caballol, B and Leo-Carnerero, E and García, M J and Bertoletti, F and Bastida, G and Suris, G and Casis, B and Ferreiro-Iglesias, R and Calafat, M and Jiménez, I and Miranda-Bautista, J and Lamuela, L J and Fajardo, I and Torrealba, L and Nájera, R and Sáiz-Chumillas, R M and González-Partida, I and Vicuña, M and García-Morales, N and Gutiérrez, A and López-García, A and Benítez, J M and Rubín de Célix, C and Tejido, C and Brunet, E and Hernandez-Camba, A and Suárez, C and Rodríguez-Lago, I and Piqueras, M and Castaño, A and Ramos, L and Sobrino, A and Rodríguez-Grau, M C and Elosua, A and Montoro, M and Baltar, R and Huguet, J M and Hermida, B and Caballero-Mateos, A and Sánchez-Guillén, L and Bouhmidi, A and Pajares, R and Baston-Rey, I and López-Sanromán, A and Albillos, A and Barreiro-de Acosta, M and GETECCU Young Members Group, GETECCU Young Members Group},
title = {Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2024.09.023}
}
EUVIMED